Bosh sahifaEXEL • NASDAQ
add
Exelixis Inc
Yopilish kursi
44,17 $
Kunlik diapazon
43,43 $ - 44,11 $
Yillik diapazon
31,90 $ - 49,40 $
Bozor kapitalizatsiyasi
11,71 mlrd USD
Oʻrtacha hajm
3,06 mln
Narx/foyda
18,38
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 597,76 mln | 10,79% |
Joriy xarajat | 322,82 mln | -3,45% |
Sof foyda | 193,58 mln | 64,09% |
Sof foyda marjasi | 32,38 | 48,06% |
Har bir ulushga tushum | 0,78 | 65,96% |
EBITDA | 263,78 mln | 35,07% |
Amaldagi soliq stavkasi | 23,31% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 988,54 mln | -16,87% |
Jami aktivlari | 2,82 mlrd | -4,62% |
Jami passivlari | 662,85 mln | -3,21% |
Umumiy kapital | 2,16 mlrd | — |
Tarqatilgan aksiyalar | 268,11 mln | — |
Narxi/balansdagi bahosi | 5,48 | — |
Aktivlardan daromad | 23,30% | — |
Kapitaldan daromad | 28,17% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 193,58 mln | 64,09% |
Operatsiyalardan naqd pul | 290,32 mln | 7,00% |
Sarmoyadan naqd pul | 25,40 mln | 111,70% |
Moliyadan naqd pul | -103,86 mln | -1 923,38% |
Naqd pulning sof oʻzgarishi | 211,87 mln | 253,78% |
Boʻsh pul | 205,41 mln | -32,03% |
Haqida
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer. Wikipedia
Tashkil etilgan
15-noy, 1994
Sayt
Xodimlar soni
1 147
